Abstract:Multiple system atrophy(MSA) is a sporadic and rapidly progressive neurodegenerative disorder that presents with autonomic failure in combination with parkinsonism or cerebellar ataxia.Advances in the early recognition of this disease have resulted in revised diagnostic criteria,including neuroimaging features,such as atrophy of putamen,middle cerebellar peduncle,pons or cerebellum on magnetic resonance imaging(MRI),hypometabolism in putamen,brainstem,or cerebellum on FDG-positron emission tomography(FDG-PET),and presynaptic nigrostriatal dopaminergic denervation on single photon emission computerized tomography(SPECT) or PET.Neuroimaging can potentially be used as a clinical biomarker in the early diagnosis of MSA.

Neuroimaging Features of Multiple System Atrophy